Please note our website will be undergoing maintenance on Tuesday, May 28, 2024. e-Commerce transactions and new registrations will be temporarily unavailable during this time. We apologize for any inconvenience this may cause.
Open access

Immunodeficiencies with hypergammaglobulinemia: a review

Publication: LymphoSign Journal
18 December 2014

Abstract

Primary immunodeficiencies (PID) can present with recurrent infections, autoimmunity, inflammation, or malignancy and each of these conditions can be associated with elevated immunoglobulin. A high level of immunoglobulin G (IgG) is an uncommon finding, especially in pediatrics, and does not rule out primary immunodeficiency. Deficiencies in varied aspects of immune response have been described with high IgG. Reported PID conditions with elevated IgG include defects in humoral, cellular, and innate immunity. Some of these immunodeficiencies can have fatal outcomes, some require hematopoetic stem cell transplantation, and some require systemic medications. The mechanisms driving elevated IgG are not well understood, but in some cases abnormal cytokine production has been proposed. The evaluation of a patient with high IgG is guided by the patient's history and a physical examination, with special attention to autoimmunity in pediatrics and malignancy and liver disease in adults. In the setting of autoimmunity, chronic gastrointestinal disease, or chronic infections, the measurement of specific antibodies to evaluate the function of the IgG should be considered. An increased appreciation of elevation in IgG reflecting immune dysregulation may lead to earlier PID diagnoses.

Formats available

You can view the full content in the following formats:

References

Aalberse R.C., Stapel S.O., Schuurman J., and Rispens T. Immunoglobulin G4: an odd antibody Clin. Exp. Allergy. 2009 39 4 469 -477
Aas-Hanssen K., Funderud A., Thompson K.M., Bogen B., and Munthe L.A. Idiotype-specific Th cells support oligoclonal expansion of anti-dsDNA B cells in mice with lupus J. Immunol. 2014 193 6 2691 -2698
Abdollahpour H., Appaswamy G., Kotlarz D., Diestelhorst J., Beier R., Schäffer A.A., Gertz E.M., Schambach A., Kreipe H.H., Pfeifer D., Engelhardt K.R., Rezaei N., Grimbacher B., Lohrmann S., Sherkat R., and Klein C. The phenotype of human STK4 deficiency Blood. 2012 119 15 3450 -3457
Alangari A., Alsultan A., Adly N., Massaad M.J., Kiani I.S., Aljebreen A., Raddaoui E., Almomen A.-K., Al-Muhsen S., Geha R.S., and Alkuraya F.S. LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency J. Allergy Clin. Immunol. 2012 130 2 481 -488.e2
Al-Herz W., Bousfiha A., Casanova J.-L., Chatila T., Conley M.E., Cunningham-Rundles C., Etzioni A., Franco J.L., Gaspar H.B., Holland S.M., Klein C., Nonoyama S., Ochs H.D., Oksenhendler E., Picard C., Puck J.M., Sullivan K., and Tang M.L.K. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency Front. Immunol. 2014 5 162
Al-Herz W. and Notarangelo L.D. Classification of primary immunodeficiency disorders: one-fits-all does not help anymore Clin. Immunol. 2012 144 1 24 -25
Arkwright P.D. and Gennery A.R. Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century Ann. NY Acad. Sci. 2011 1238 7 -14
Atkinson T.P. Immune deficiency and autoimmunity Curr. Opin. Rheumatol. 2012 24 5 515 -521
Avila E.M., Uzel G., Hsu A., Milner J.D., Turner M.L., Pittaluga S., Freeman A.F., and Holland S.M. Highly variable clinical phenotypes of hypomorphic RAG1 mutations Pediatrics. 2010 126 5 e1248 -e1252
Bader-Meunier B., Florkin B., Sibilia J., Acquaviva C., Hachulla E., Grateau G., Richer O., Farber C.M., Fischbach M., Hentgen V., Jego P., Laroche C., Neven B., Lequerré T., Mathian A., Pellier I., Touitou I., Rabier D., Prieur A.-M., Cuisset L., and Quartier P. Mevalonate kinase deficiency: a survey of 50 patients Pediatrics. 2011 128 1 e152 -e159
Bakri Hassan A., Rönnelid J., Gunnarsson I., Karlsson G., Berg L., and Lundberg I. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease J. Autoimmun. 1998 11 5 503 -508
Boztug K. and Klein C. Genetics and pathophysiology of severe congenital neutropenia syndromes unrelated to neutrophil elastase Hematol. Oncol. Clin. North Am. 2013 27 1 43 -60, vii
Cantarini L., Lucherini O.M., Muscari I., Frediani B., Galeazzi M., Brizi M.G., Simonini G., and Cimaz R. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives Autoimmun. Rev. 2012 12 1 38 -43
Chandesris M.-O., Melki I., Natividad A., Puel A., Fieschi C., Yun L., Thumerelle C., Oksenhendler E., Boutboul D., Thomas C., Hoarau C., Lebranchu Y., Stephan J.-L., Cazorla C., Aladjidi N., Micheau M., Tron F., Baruchel A., Barlogis V., Palenzuela G., Mathey C., Dominique S., Body G., Munzer M., Fouyssac F., Jaussaud R., Bader-Meunier B., Mahlaoui N., Blanche S., Debré M., Le Bourgeois M., Gandemer V., Lambert N., Grandin V., Ndaga S., Jacques C., Harre C., Forveille M., Alyanakian M.-A., Durandy A., Bodemer C., Suarez F., Hermine O., Lortholary O., Casanova J.-L., Fischer A., and Picard C. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey Medicine (Baltimore). 2012 91 4 e1 -e19
Chen K., Wu W., Mathew D., Zhang Y., Browne S.K., Rosen L.B., McManus M.P., Pulsipher M.A., Yandell M., Bohnsack J.F., Jorde L.B., Notarangelo L.D., and Walter J.E. Autoimmunity due to RAG deficiency and estimated disease incidence in RAG1/2 mutations J. Allergy Clin. Immunol. 2014 133 3 880 -882.e10
Costa-Carvalho B.T., Grumach A.S., Franco J.L., Espinosa-Rosales F.J., Leiva L.E., King A., Porras O., Bezrodnik L., Oleastro M., Sorensen R.U., and Condino-Neto A. Attending to warning signs of primary immunodeficiency diseases across the range of clinical practice J. Clin. Immunol. 2014 34 1 10 -22
Cunningham-Rundles C. Autoimmunity in primary immune deficiency: taking lessons from our patients Clin. Exp. Immunol. 2011 164 6 -11
De Miranda N.F., Björkman A., and Pan-Hammarström Q. DNA repair: the link between primary immunodeficiency and cancer Ann. NY Acad. Sci. 2011 1246 50 -63
Dispenzieri A., Gertz M.A., Therneau T.M., and Kyle R.A. Retrospective cohort study of 148 patients with polyclonal gammopathy Mayo Clin. Proc. 2001 76 5 476 -487
Du X., Shi H., Li J., Dong Y., Liang J., Ye J., Kong S., Zhang S., Zhong T., Yuan Z., Xu T., Zhuang Y., Zheng B., Geng J.-G., and Tao W. Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease J. Immunol. 2014 192 4 1525 -1535
Engelhardt K.R., Mcghee S., Winkler S., Sassi A., Woellner C., Lopez-herrera G., Chen A., Kim H.S., Lloret M.G., Schulze I., Ehl S., Thiel J., Pfeifer D., Veelken H., Niehues T., Siepermann K., Weinspach S., Reisli I., Keles S., and Genel F. Large deletions and point mutations involving DOCK8 in the autosomal recessive form of the hyper-IgE syndrome J. Allergy Clin. Immunol. 2009 124 6 1289 -1302
Feske S., Picard C., and Fischer A. Immunodeficiency due to mutations in ORAI1 and STIM1 Clin. Immunol. 2010 135 2 169 -182
Fischer A., Picard C., Chemin K., Dogniaux S., le Deist F., and Hivroz C. ZAP70: a master regulator of adaptive immunity Semin. Immunopathol. 2010 32 2 107 -116
Fonseca R. and Monge J. Myeloma: classification and risk assessment Semin. Oncol. 2013 40 5 554 -566
Freeman A.F. and Holland S.M. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes Pediatr. Res. 2009 65 5 Pt 2 32R -37R
Gallo V., Giardino G., Capalbo D., Palamaro L., Romano R., Santamaria F., Maio F., Salerno M., Vajro P., and Pignata C. Alterations of the autoimmune regulator transcription factor and failure of central tolerance: APECED as a model Expert Rev. Clin. Immunol. 2013 9 1 43 -51
Geha R.S., Notarangelo L.D., Casanova J.-L., Chapel H., Conley M.E., Fischer A., Hammarström L., Nonoyama S., Ochs H.D., Puck J.M., Roifman C., Seger R., and Wedgwood J. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee J. Allergy Clin. Immunol. 2007 120 4 776 -794
Goldbach-Mansky R. Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1 Clin. Exp. Immunol. 2012 167 3 391 -404
Goyal R., Bulua A.C., Nikolov N.P., Schwartzberg P.L., and Siegel R.M. Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders Curr. Opin. Rheumatol. 2009 21 1 78 -84
Hanada T., Okuno K., Okada S., Fujimoto M., Kuranobu H., Hashida Y., Ueyama J., Murakami J., Hayashi A., Hanaki K., and Kanzaki S. Castleman disease in a child with short stature Pediatr. Int. 2012 54 5 720 -724
Hanson E.P., Monaco-Shawver L., Solt L.A., Madge L.A., Banerjee P.P., May M.J., and Orange J.S. Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity J. Allergy Clin. Immunol. 2008 122 6 1169 -1177.e16
Henderson L.A., Frugoni F., Hopkins G., de Boer H., Pai S.-Y., Lee Y.N., Walter J.E., Hazen M.M., and Notarangelo L.D. Expanding the spectrum of recombination-activating gene 1 deficiency: a family with early-onset autoimmunity J. Allergy Clin. Immunol. 2013 132 4 969 -971.e1–2
Holland S.M. Chronic granulomatous disease Hematol. Oncol. Clin. North Am. 2013 27 1 89 -99, viii
Horwitz M.S., Corey S.J., Grimes H.L., and Tidwell T. ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology Hematol. Oncol. Clin. North Am. 2013 27 1 19 -41, vii
Hunziker L., Recher M., Macpherson A. J., Ciurea A., Freigang S., Hengartner H., and Zinkernagel R.M. Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections Nat. Immunol. 2003 4 4 343 -349
Immunodeficiency Canada. 2014. Red Flags for Primary Immunodeficiency. Retrieved September 21, 2014, from http://immunodeficiency.ca/primary-immunodeficiency/warning-signs/.
Janssen E., Tsitsikov E., Al-Herz W., Lefranc G., Megarbane A., Dasouki M., Bonilla F.A., Chatila T., Schneider L., and Geha R.S. Flow cytometry biomarkers distinguish DOCK8 deficiency from severe atopic dermatitis Clin. Immunol. 2014 150 2 220 -224
Jeffrey Model Foundation. 2013. 10 Warning Signs. Retrieved July 17, 2014, from http://www.info4pi.org/library/educational-materials/10-warning-signs.
Jesus A. A. and Goldbach-Mansky R. IL-1 blockade in autoinflammatory syndromes Annu. Rev. Med. 2014 65 223 -244
Judge M.R., Morgan G., and Harper J.I. A clinical and immunological study of Netherton's syndrome Br. J. Dermatol. 1994 131 5 615 -621 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/7999590
Kaplan J., De Domenico I., and Ward D.M. Chediak-Higashi syndrome Curr. Opin. Hematol. 2008 15 1 22 -29
Kastner D.L., Aksentijevich I., and Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective Cell. 2010 140 6 784 -790
Kavadas F.D., Giliani S., Gu Y., Mazzolari E., Bates A., Pegoiani E., Roifman C.M., and Notarangelo L.D. Variability of clinical and laboratory features among patients with ribonuclease mitochondrial RNA processing endoribonuclease gene mutations J. Allergy Clin. Immunol. 2008 122 6 1178 -1184
Ku C.-L., von Bernuth H., Picard C., Zhang S.-Y., Chang H.-H., Yang K., Chrabieh M., Issekutz A.C., Cunningham C.K., Gallin J., Holland S.M., Roifman C., Ehl S., Smart J., Tang M., Barrat F.J., Levy O., McDonald D., Day-Good N.K., Miller R., Takada H., Hara T., Al-Hajjar S., Al-Ghonaium A., Speert D., Sanlaville D., Li X., Geissmann F., Vivier E., Maródi L., Garty B.-Z., Chapel H., Rodriguez-Gallego C., Bossuyt X., Abel L., Puel A., and Casanova J.-L. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity J. Exp. Med. 2007 204 10 2407 -2422
Kurosawa S., Akiyama N., Ohwada A., Warabi M., Suenaga M., Kojima M., and Tomiyama J. Idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia accompanied with cutaneous involvement and renal dysfunction Jpn. J. Clin. Oncol. 2009 39 10 682 -685
Kutlubay Z., Bairamov O., Sevim A., Demirkesen C., and Mat M.C. Rosai-Dorfman disease: a case report with nodal and cutaneous involvement and review of the literature Am. J. Dermatopathol. 2014 36 4 353 -357
Leechawengwongs E. and Shearer W.T. Lymphoma complicating primary immunodeficiency syndromes Curr. Opin. Hematol. 2012 19 4 305 -312
Leffler J., Bengtsson A.A., and Blom A.M. The complement system in systemic lupus erythematosus: an update Ann. Rheum. Dis. 2014 73 9 1601 -1606
Leonard G.D., Posadas E., Herrmann P.C., Anderson V.L., Jaffe E.S., Holland S.M., and Wilson W.H. Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review Leuk. Lymphoma. 2004 45 12 2521 -2525
Lo M.S., Zurakowski D., Son M.B.F., and Sundel R.P. Hypergammaglobulinemia in the pediatric population as a marker for underlying autoimmune disease: a retrospective cohort study Pediatr. Rheumatol. Online J. 2013 11 1 42
Locke B.A., Dasu T., and Verbsky J.W. Laboratory diagnosis of primary immunodeficiencies Clin. Rev. Allergy Immunol. 2014 46 2 154 -168
Maggina P. and Gennery A.R. Classification of primary immunodeficiencies: need for a revised approach? J. Allergy Clin. Immunol. 2013 131 2 292 -294
Massaad M.J., Ramesh N., and Geha R.S. Wiskott-Aldrich syndrome: a comprehensive review Ann. NY Acad. Sci. 2013 1285 26 -43
Mayilyan K.R. Complement genetics, deficiencies, and disease associations Prot. Cell. 2012 3 7 487 -496
McDonald D.R., Goldman F., Gomez-Duarte O.D., Issekutz A.C., Kumararatne D.S., Doffinger R., and Geha R.S. Impaired T-cell receptor activation in IL-1 receptor-associated kinase-4-deficient patients J. Allergy Clin. Immunol. 2010 126 2 332 -337.e1–2
Merino F., Klein G.O., Henle W., Ramirez-Duque P., Forsgren M., and Amesty C. Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndrome Clin. Immunol. Immunopathol. 1983 27 3 326 -339
Michel M., Chanet V., Galicier L., Ruivard M., Levy Y., Hermine O., Oksenhendler E., Schaeffer A., Bierling P., and Godeau B. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature Medicine (Baltimore). 2004 83 4 254 -263 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15232313
Minegishi Y. and Karasuyama H. Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency Int. Immunol. 2009 21 2 105 -112
Nagumo H. and Komiyama A. [Antibody deficiency with normal(or elevated) immunoglobulins] Ryoikibetsu Shokogun Shirizu. 2000 32 66 -68 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11212825
Nehme N.T., Pachlopnik Schmid J., Debeurme F., André-Schmutz I., Lim A., Nitschke P., Rieux-Laucat F., Lutz P., Picard C., Mahlaoui N., Fischer A., and de Saint Basile G. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival Blood. 2012 119 15 3458 -3468
Nishikimi A., Kukimoto-Niino M., Yokoyama S., and Fukui Y. Immune regulatory functions of DOCK family proteins in health and disease Exp. Cell Res. 2013 319 15 2343 -2349
Notarangelo L.D., Fischer A., Geha R.S., Casanova J.-L., Chapel H., Conley M.E., Cunningham-Rundles C., Etzioni A., Hammartröm L., Nonoyama S., Ochs H.D., Puck J., Roifman C., Seger R., and Wedgwood J. Primary immunodeficiencies: 2009 update J. Allergy Clin. Immunol. 2009 124 6 1161 -1178
Nowak-Wegrzyn A., Crawford T.O., Winkelstein J.A., Carson K.A., and Lederman H.M. Immunodeficiency and infections in ataxia-telangiectasia J. Pediatr. 2004 144 4 505 -511
Ochs H.D. Patients with abnormal IgM levels: assessment, clinical interpretation, and treatment Ann. Allergy. Asthma Immunol. 2008 100 5 509 -511
Oliveira J.B., Bleesing J.J., Dianzani U., Fleisher T.A., Jaffe E.S., Lenardo M.J., Rieux-laucat F., Siegel R.M., Su H.C., Teachey D.T., and Rao V.K. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. 2010 116 14 35 -40
Orange J.S., Ballow M., Stiehm E.R., Ballas Z.K., Chinen J., De La Morena M., Kumararatne D., Harville T.O., Hesterberg P., Koleilat M., McGhee S., Perez E.E., Raasch J., Scherzer R., Schroeder H., Seroogy C., Huissoon A., Sorensen R.U., and Katial R. Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology J. Allergy Clin. Immunol. 2012 130 3 S1 -S24
Pachlopnik Schmid J., Canioni D., Moshous D., Touzot F., Mahlaoui N., Hauck F., Kanegane H., Lopez-Granados E., Mejstrikova E., Pellier I., Galicier L., Galambrun C., Barlogis V., Bordigoni P., Fourmaintraux A., Hamidou M., Dabadie A., Le Deist F., Haerynck F., Ouachée-Chardin M., Rohrlich P., Stephan J.-L., Lenoir C., Rigaud S., Lambert N., Milili M., Schiff C., Chapel H., Picard C., de Saint Basile G., Blanche S., Fischer A., and Latour S. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency) Blood. 2011 117 5 1522 -1529
Parvaneh N., Filipovich A.H., and Borkhardt A. Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases Br. J. Haematol. 2013 162 5 573 -586
Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy J. Clin. Endocrinol. Metab. 2006 91 8 2843 -2850
Picard C., von Bernuth H., Ghandil P., Chrabieh M., Levy O., Arkwright P.D., McDonald D., Geha R.S., Takada H., Krause J.C., Creech C.B., Ku C.-L., Ehl S., Maródi L., Al-Muhsen S., Al-Hajjar S., Al-Ghonaium A., Day-Good N.K., Holland S.M., Gallin J.I., Chapel H., Speert D.P., Rodriguez-Gallego C., Colino E., Garty B.-Z., Roifman C., Hara T., Yoshikawa H., Nonoyama S., Domachowske J., Issekutz A.C., Tang M., Smart J., Zitnik S.E., Hoarau C., Kumararatne D.S., Thrasher A.J., Davies E.G., Bethune C., Sirvent N., de Ricaud D., Camcioglu Y., Vasconcelos J., Guedes M., Vitor A.B., Rodrigo C., Almazán F., Méndez M., Aróstegui J.I., Alsina L., Fortuny C., Reichenbach J., Verbsky J.W., Bossuyt X., Doffinger R., Abel L., Puel A., and Casanova J.-L. Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency Medicine (Baltimore). 2010 89 6 403 -425
Puel A., Cypowyj S., Bustamante J., Wright J.F., Liu L., Lim H.K., Migaud M., Israel L., Chrabieh M., Audry M., Gumbleton M., Toulon A., Bodemer C., El-Baghdadi J., Whitters M., Paradis T., Brooks J., Collins M., Wolfman N.M., Al-Muhsen S., Galicchio M., Abel L., Picard C., and Casanova J.-L. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity Science. 2011 332 6025 65 -68
Puel A., Döffinger R., Natividad A., Chrabieh M., Barcenas-Morales G., Picard C., Cobat A., Ouachée-Chardin M., Toulon A., Bustamante J., Al-Muhsen S., Al-Owain M., Arkwright P.D., Costigan C., McConnell V., Cant A.J., Abinun M., Polak M., Bougnères P.-F., Kumararatne D., Marodi L., Nahum A., Roifman C., Blanche S., Fischer A., Bodemer C., Abel L., Lilic D., and Casanova J.-L. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I J. Exp. Med. 2010a 207 2 291 -297
Puel A., Picard C., Cypowyj S., Lilic D., Abel L., and Casanova J.-L. Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines? Curr. Opin. Immunol. 2010b 22 4 467 -474
Randall K.L., Lambe T., Johnson A.L., Johnson A., Treanor B., Kucharska E., Domaschenz H., Whittle B., Tze L.E., Enders A., Crockford T.L., Bouriez-Jones T., Alston D., Cyster J.G., Lenardo M.J., Mackay F., Deenick E.K., Tangye S.G., Chan T.D., Camidge T., Brink R., Vinuesa C.G., Batista F.D., Cornall R.J., and Goodnow C.C. Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production Nat. Immunol. 2009 10 12 1283 -1291
Rao V.K. and Oliveira J.B. How I treat autoimmune lymphoproliferative syndrome Blood. 2011 118 22 5741 -5751
Rensing-Ehl A., Warnatz K., Fuchs S., Schlesier M., Salzer U., Draeger R., Bondzio I., Joos Y., Janda A., Gomes M., Abinun M., Hambleton S., Cant A., Shackley F., Flood T., Waruiru C., Beutel K., Siepermann K., Dueckers G., Niehues T., Wiesel T., Schuster V., Seidel M.G., Minkov M., Sirkiä K., Kopp M.V., Korhonen M., Schwarz K., Ehl S., and Speckmann C. Clinical and immunological overlap between autoimmune lymphoproliferative syndrome and common variable immunodeficiency Clin. Immunol. 2010 137 3 357 -365
Roberts J.L., Schwartz M.M., and Lewis E.J. Hereditary C2 deficiency and systemic lupus erythematosus associated with severe glomerulonephritis Clin. Exp. Immunol. 1978 31 2 328 -338 Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1541209&tool=pmcentrez&rendertype=abstract
Schauer U., Stemberg F., Rieger C.H.L., Borte M., Schubert S., Riedel F., Herz U., Renz H., Wick M., Carr-Smith H.D., Bradwell A.R., and Herzog W. IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagents Clin. Chem. 2003 49 11 1924 -1929 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/14578325
Schuetz C., Niehues T., Friedrich W., and Schwarz K. Autoimmunity, autoinflammation and lymphoma in combined immunodeficiency (CID) Autoimmun. Rev. 2010 9 7 477 -482
Schuster C., Kränke B., Aberer E., Arbab E., Sturm G., and Aberer W. Schnitzler syndrome: response to anakinra in two cases and a review of the literature Int. J. Dermatol. 2009 48 11 1190 -1194
Sfriso P., Caso F., Tognon S., Galozzi P., Gava A., and Punzi L. Blau syndrome, clinical and genetic aspects Autoimmun. Rev. 2012 12 1 44 -51
Sharfe N., Dadi H.K., Shahar M., and Roifman C.M. Human immune disorder arising from mutation of the chain of the interleukin-2 receptor Proc. Natl. Acad. Sci. 1997 94 7 3168 -3171
Sharfe N., Nahum A., Newell A., Dadi H., Ngan B., Pereira S.L., Herbrick J.-A., and Roifman C.M. Fatal combined immunodeficiency associated with heterozygous mutation in STAT1 J. Allergy Clin. Immunol. 2014 133 3 807 -817
Sowerwine K.J., Holland S.M., and Freeman A.F. Hyper-IgE syndrome update Ann. NY Acad. Sci. 2012 1250 25 -32
Su H.C., Jing H., and Zhang Q. DOCK8 deficiency Ann. NY Acad. Sci. 2011 1246 26 -33
Subbarayan A., Colarusso G., Hughes S.M., Gennery A.R., Slatter M., Cant A.J., and Arkwright P.D. Clinical features that identify children with primary immunodeficiency diseases Pediatrics. 2011 127 5 810 -816
Sweet R.A., Lee S.K., and Vinuesa C.G. Developing connections amongst key cytokines and dysregulated germinal centers in autoimmunity Curr. Opin. Immunol. 2012 24 6 658 -664
Tardieu M., Lacroix C., Basile D. Saint, and Fischer A. Brief report progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome Blood. 2005 106 1 40 -42
Todoric K., Koontz J.B., Mattox D., and Tarrant T.K. Autoimmunity in immunodeficiency Curr. Allergy Asthma Rep. 2013 13 4 361 -370
Torgerson T.R. Immunodeficiency diseases with rheumatic manifestations Pediatr. Clin. North Am. 2012 59 2 493 -507
Uhlig H.H. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease Gut. 2013 62 12 1795 -1805
Uzel G., Sampaio E.P., Lawrence M.G., Hsu A.P., Hackett M., Dorsey M.J., Noel R.J., Verbsky J.W., Freeman A.F., Janssen E., Bonilla F.A, Pechacek J., Chandrasekaran P., Browne S.K., Agharahimi A., Gharib A.M., Mannurita S.C., Yim J.J., Gambineri E., Torgerson T., Tran D.Q., Milner J.D., and Holland S.M. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome J. Allergy Clin. Immunol. 2013 131 6 1611 -1623
Van Montfrans J.M., Hoepelman A.I.M., Otto S., van Gijn M., van de Corput L., de Weger R.A., Monaco-Shawver L., Banerjee P.P., Sanders E.A.M., Jol-van der Zijde C.M., Betts M.R., Orange J.S., Bloem A.C., and Tesselaar K. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia J. Allergy Clin. Immunol. 2012 129 3 787 -793.e6
Verbsky J.W. and Chatila T.A. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases Curr. Opin. Pediatr. 2013 25 6 708 -714
Villa A., Notarangelo L.D., and Roifman C.M. Omenn syndrome: inflammation in leaky severe combined immunodeficiency J. Allergy Clin. Immunol. 2008 122 6 1082 -1086
Von Bernuth H., Picard C., Puel A., and Casanova J.-L. Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans Eur. J. Immunol. 2012 42 12 3126 -3135
Wood P., Stanworth S., Burton J., Jones A, Peckham D.G., Green T., Hyde C., and Chapel H. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review Clin. Exp. Immunol. 2007 149 3 410 -423
Zhang Q., Davis J.C., Lamborn I.T., Freeman A.F., Jing H., Favreau A.J., Matthews H.F., Davis J., Turner M.L., Uzel G., Holland S.M., and Su H.C. Combined immunodeficiency associated with DOCK8 mutations N. Engl. J. Med. 2009 361 21 2046 -2055

Information & Authors

Information

Published In

cover image LymphoSign Journal
LymphoSign Journal
Volume 2Number 2June 2015
Pages: 57 - 73

History

Received: 12 December 2014
Accepted: 17 December 2014
Accepted manuscript online: 17 December 2014
Version of record online: 18 December 2014

Authors

Affiliations

Julia Upton [email protected]
Division of Clinical Immunology and Allergy, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

Metrics & Citations

Metrics

Other Metrics

Citations

Cite As

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

Cited by

1. Elevated serum gamma globulins in apparently healthy Nigerians living in Ogbomoso: a possible manifestation of phagocytic dysfunction

View Options

View options

PDF

View PDF

Full Text

View Full Text

Get Access

Login options

Check if you access through your login credentials or your institution to get full access on this article.

Subscribe

Click on the button below to subscribe to LymphoSign Journal

Purchase options

Purchase this article to get full access to it.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Media

Media

Other

Tables

Share Options

Share

Share the article link

Share on social media